201 related articles for article (PubMed ID: 19724222)
1. Lymphocyte markers and prediction of long-term renal allograft acceptance.
Babel N; Reinke P; Volk HD
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
Lunsford KE; Barbas AS; Brennan TV
Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the operationally tolerant liver allograft recipient.
Castellaneta A; Thomson AW; Nayyar N; de Vera M; Mazariegos GV
Curr Opin Organ Transplant; 2010 Feb; 15(1):28-34. PubMed ID: 19890211
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the effects of CMV on long-term transplant outcome.
Baron C; Forconi C; Lebranchu Y
Curr Opin Organ Transplant; 2010 Aug; 15(4):492-8. PubMed ID: 20631617
[TBL] [Abstract][Full Text] [Related]
5. Conclusions from the symposium.
Campistol JM
Transplant Proc; 2010 Nov; 42(9 Suppl):S47-8. PubMed ID: 21095453
[TBL] [Abstract][Full Text] [Related]
6. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia.
Turka LA; Wood K; Bluestone JA
Curr Opin Organ Transplant; 2010 Aug; 15(4):441-8. PubMed ID: 20631613
[TBL] [Abstract][Full Text] [Related]
7. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation?
Pons JA; Revilla Nuin B; Ramírez P; Baroja Mazo A; Martínez Alarcón L; Robles R; Sánchez Bueno F; Rios A; Cascales Campos P; Parrilla P
Transplant Proc; 2012; 44(6):1530-2. PubMed ID: 22841204
[TBL] [Abstract][Full Text] [Related]
8. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
9. Operational tolerance: past lessons and future prospects.
Levitsky J
Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
11. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.
Barraclough KA; Staatz CE; Isbel NM; McTaggart SJ
Nephrology (Carlton); 2010 Aug; 15(5):522-32. PubMed ID: 20649871
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in renal transplantation.
Bestard O; Cruzado JM; la Franquesa M; Grinyó JM
Curr Opin Organ Transplant; 2010 Aug; 15(4):467-73. PubMed ID: 20613522
[TBL] [Abstract][Full Text] [Related]
13. Approaching the promise of operational tolerance in clinical transplantation.
Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
[TBL] [Abstract][Full Text] [Related]
14. Rejection and acceptance of corneal allografts.
Klebe S; Coster DJ; Williams KA
Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
[TBL] [Abstract][Full Text] [Related]
15. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
Danger R; Giral M; Soulillou JP; Brouard S
Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes and quality of life after intestine transplantation.
Sudan D
Curr Opin Organ Transplant; 2010 Jun; 15(3):357-60. PubMed ID: 20445450
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant immune risk assessment.
Sawitzki B; Schlickeiser S; Reinke P; Volk HD
Curr Opin Organ Transplant; 2009 Dec; 14(6):650-5. PubMed ID: 19779344
[TBL] [Abstract][Full Text] [Related]
18. Can we use biomarkers and functional assays to implement personalized therapies in transplantation?
Sawitzki B; Pascher A; Babel N; Reinke P; Volk HD
Transplantation; 2009 Jun; 87(11):1595-601. PubMed ID: 19502949
[TBL] [Abstract][Full Text] [Related]
19. [Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation].
Sperschneider H; Heemann U; Stein G
Med Klin (Munich); 2003 Mar; 98(3):140-5. PubMed ID: 12647088
[TBL] [Abstract][Full Text] [Related]
20. Clinical renal transplantation: where are we now, what are our key challenges?
Chapman JR
Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
